Anti-hypertensive effect of Chunghyul-dan (Qingxue-dan) on stroke patients with essential hypertension

American Journal of Chinese Medicine

Volumn 33, Issue 3, 2005, Pages 357-364

  Yun, Sang Pil ^a   Jung, Woo Sang ^a   Park, Seong Uk ^a   Moon, Sang Kwan ^a   Ko, Chang Nam ^a   Cho, Ki Ho ^a   Kim, Young Suk ^a   Bae, Hyung Sup ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Chunghyul dan; Coptidis Rhizoma; Hypertension; Phellodendri Cortex; Scutellariae Radix; SI; Stroke; TPR

Indexed keywords

CHINESE DRUG; CHUNGHYUL DAN; COPTIS RHIZOME; GARDENIA EXTRACT; PHELLODENDRON AMURENSE EXTRACT; QINGXUE DAN; RHUBARB EXTRACT; SCUTELLARIAE RADIX; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CHINESE MEDICINE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG CAPSULE; DRUG EFFICACY; DRUG SAFETY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STROKE; SYSTOLIC BLOOD PRESSURE;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; CEREBROVASCULAR ACCIDENT; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RECURRENCE; SYSTOLE;

EID: 21344474380     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X05002977     Document Type: Article

References (28)

1. Antonicelli, R., S. Omboni, D.C. Giovanni, R. Ansuini, A. Mori and R. Gesuita. Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: Evaluation by 24-hour ambulatory blood pressure monitoring. Drugs Aging 19(7): 541-551, 2002.
2. Bosch, J., S. Yusuf, J. Pogue, P. Sleight, E. Lonn and B. Rangoonwala, et al. Use of ramipril in preventing stroke: Double blind randomized trial. Br. Med. J. 324: 1-5, 2002.
3. Cho, K.H., W.S. Jung, S.W. Park, S.K. Moon, Y.S. Kim and H.S. Bae. Clinical assessment on the safety of Chunghyul-dan. J. Korean Orient. Med. 24(3): 45-50, 2003.
4. Guidelines Committee. 2003 European society of hypertension-european society of cardiology guidelines for the management of arterial hypertension. J. Hypertens. 21: 1011-1053, 2003.
5. Hayakawa, J., N. Noda, S. Yamada, E. Mikami, K. Uno and Z. Yakugadu. Studies on physical chemical quality evaluation of crude drugs preparations. III. Analysis of gardenia fruits and its preparations. Yakugaku Zasshi 105(10): 996-1000, 1986.
6. Jang, J.C., W.S. Jung, S.K. Moon, K.H. Cho, Y.S. Kim and H.S. Bae. Effect of Chunghyul-dan on anit-oxidation. J. Korean Orient. Med., 2004 (in press).
7. Kannel, W.B. Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile. Am. Heart J. 138: 205-210, 1999.
8. Kim, Y.S., E.A. Jung, J.E. Shin, J.C. Chung, H.K. Yang and N.J. Kim. Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase. Biol. Pharm. Bull. 25(11): 1442-1445, 2002.
9. MacMahon, S., R. Peto, J. Cutler, R. Collins, P. Sorlie and J. Neaton. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 335: 765-774, 1990.
10. MacMahon, S. and A. Rodgers. Blood pressure, anti-hypertensive treatment and stroke risk. J. Hypertens. 12(Suppl. 10): S5-S14, 1994.
11. Meredith, P.A. Role of trough to peak efficacy in the evaluation of anti-hypertensive treatment. J. Hypertens. 16: S59-S64, 1998.
12. Neutel, J.M. The importance of 24-hour blood pressure control. Blood Press. Monit. 6(1): 9-16, 2001.
13. Omboni, S., G. Parati, A. Zanchetti and G. Mancia. Calculation of trough:peak ratio of anti-hypertensive treatment from ambulatory blood pressure: Methodological aspects. J. Hypertens. 13: 1105-1112, 1995.
14. Parati, G., S. Omboni, D. Rizzoni, E. Agabiti-Rosei and G. Mancia. The smoothness index: A new, reproducible and clinically relevant measure of the homogenity of the blood pressure reduction with treatment for hypertension. J. Hypertens. 16: 1685-1691, 1998.
15. Pierre, A. Blood pressure and lipid lowering in the prevention of stroke: a note to neurologists. Cerebrovasc. Dis. 16: 33-38, 2003.
16. Progress Collaborative Group. Randomized trial of perindopril based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358: 1033-1041, 2001.
17. Proposed Guidelines for the Clinical Evaluation of Anti-hypertensive Drug Products (Draft). FDA Division of Cardi-renal Drug Products, Rockville, Maryland, 1998, p. 4.
18. Rizzoni, D., M. Castellano, M.L. Muiesan, E. Porteri and E. Agabiti-Rosei. Beyond trough:peak ratio: A new index of the smoothness of the anti-hypertensive effect of a drug. High Blood Press. 6: 110-115, 1997.
19. Rizzoni, D., M.L. Muiesan, M. Salvetti, M. Castellano, G. Bettoni and C. Monteduro, et al. The smoothness index, but not the trough-to-peak ratio predicts changes in carotid artery wall thickness during anti-hypertensive treatment. J. Hypertens. 19(4): 703-711, 2001.
20. Sanae, F., Y. Komatsu, S. Amagaya, K. Chisaki and H. Hayashi. Effects of nine kampo medicines clinically used in hypertension on hemodynamic changes induced by theophylline in rats. Biol. Pharm. Bull. 23(6): 762-765, 2000.
21. Sanae, F., Y. Komatsu, K. Chisaki, T. Kido, A. Isige and H. Hayashi. Effects of san'o sashin-to and the constituent herbal medicines on theophylline-induced increase in arterial blood pressure on rats. Biol. Pharm. Bull. 24(10): 1137-1141, 2001.
22. SHEP Cooperative Research Group. Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265(24): 3255-3264, 1991.
23. Staessen, J.A., L. Thijs, J. Gasowski, H. Cells and R.H. Fagard. Treatment of isolated systolic hypertension in the elderly: Further evidence from the systolic hypertension in Europe (Syst-Eur) trial. Am. J. Cardiol. 82(9B): 20R-22R, 1998.
24. Stamler, J., R. Stamler and J.D. Neaton. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch. Intern. Med. 148: 1023-1038, 1993.
25. Stergiou, G.S., S.P. Efstathiou, L.G. Roussias and T.D. Mountokalakis. Blood pressure- and pulse pressure-lowering effects, trough:peak ratio and smoothness index of telmisartan compared with lisinopril. J. Cardiovasc. Pharmacol. 42(4): 491-496, 2003.
26. The National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure - the JNC report. JAMA 289: 2560-2572, 2003.
27. Yun, S.P., L.D. Kim, S.H. Lee, E.J. Kim, T.H. Kim, D.W. Jung and W.J. Shin. Effects of Chunghyul-dan on stage 1 hypertensive patients with stroke - preliminary study for optimal dose. Korean J. Orient. Int. Med. Spring: 74-81, 2004.
28. Wallace, J.D. and L.L. Levy. Blood pressure after stroke. JAMA 246: 2177-2180, 1981.